Harbeck, Nadia

ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP)

Wong, E. Y. T., Verlingue, L., Aldea, M., Franzoi, M. A., Umeton, R., Halabi, S., Harbeck, N., Indini, A., Prelaj, A., Romano, E., et al. (2025) · Annals of Oncology

Artificial Intelligence in Healthcare and EducationElectronic Health Records Systems

Cited by 44

EHealth acceptance and new media preferences for therapy assistance among breast cancer patients.

Drewes, C., Kirkovits, T., Schiltz, D., Schinkoethe, T., Haidinger, R., Goldmann-Posch, U., Harbeck, N., & Wuerstlein, R. (2016) · JMIR Cancer

Mobile Health and mHealth ApplicationsHealth Literacy and Information Accessibility

Cited by 40

Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib

Tripathy, D., Im, S.-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S., Chow, L., Sohn, J., Lee, K. S., et al. (2021) · Cancer Research

Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies

Cited by 30